Clinical trial
The Vertebral Bone Marrow Clot as Autologous Cell-therapy and Multifunctional Bio-scaffold Targeting the Key Challenges for Spinal Fusion Surgery
NCT05947175 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Vertebral Bone Marrow Clot as Autologous Cell-therapy and Multifunctional Bio-scaffold Targeting the Key Challenges for Spinal Fusion Surgery
- Lead sponsor
- Istituto Ortopedico Rizzoli
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 19, 2023
- Completion date
- May 18, 2027
- Enrollment
- 96 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative spine diseases